Sarepta Therapeutics
Sarepta Therapeutics is a biotechnology company pioneering genetic medicines for rare diseases, including Duchenne muscular dystrophy. The Patient Affairs Intern will gain hands-on exposure to rare disease patient advocacy, community engagement, and how patient perspectives inform drug development. This 12-week summer internship provides experience across patient engagement, operations, grants, and patient science programs with some on-site work in Cambridge, MA.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
We are focused on the development of precision genetic medicines to treat rare neuromuscular and central nervous system diseases. Learn more about Sarepta.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Sarepta Therapeutics.
Sarepta Therapeutics CEO Doug Ingram will retire after a tumultuous decade
2 weeks ago
Principal Biostatistician
Entrada Therapeutics
Executive Director, Investor Relations
Entrada Therapeutics
Senior Director, Medical Affairs
Capricor Therapeutics
Senior Director, Medical Affairs
Capricor Therapeutics
Senior Director, Medical Information
Dyne Therapeutics
Rare Disease Account Manager- Mountain West Region
IQVIA